Janssen files BPCIA patent suit against an impending Alvotech golimumab biosimilar, and Samsung Bioepis releases positive phase 3 trial results Golimumab Patent Battle for Alvotech and Bio-Thera Biosimilars Alleging patent infringement, Janssen Biotech filed BPCIA litigation in US District Court for the Eastern District of Virginia against Alvotech involving AVT05, its golimumab biosimilar candidates. According … Continue reading Biosimilar Bytes: Golimumab Patent Litigation, Positive Keytruda Biosimilar Trial Results